"We are a highly dedicated group of experts who are dedicated to tackling some of the biggest challenges in medicine. We are leveraging specialist in-house capabilities and strategic partnerships with leading researchers to address various types of cancer and autoimmune diseases such as lupus, as well as developing technologies that will improve the effectiveness of mRNA vaccines. Our strategy is to deploy innovative approaches to developing new drugs, principally through research and development programs that explore the very building blocks of new treatments - the molecules and compounds that may one day save lives."
Dr Gisela Mautner, CEO
